House Ways and Means Committee leaders today released a summarizing stakeholder recommendations for Medicare-related legislation to address the opioid crisis, which the committee plans to use to develop and advance bipartisan policies. The committee in February requested feedback on specific questions related to overprescribing, data tracking, beneficiary notification, provider education, and treatment options. 鈥淲e are hopeful this legislation will touch on many of the stakeholder recommendations, including but not limited to those related to Medicare treatment options/coverage, improving data tracking/prescribing practices, and educating providers and beneficiaries about the risks of long-term opioid use,鈥 the white paper states. AHA submitted its policy recommendations to the committee last month.

Related News Articles

Headline
The Food and Drug Administration July 31 announced that it is requiring safety label changes to all opioid pain medications to further emphasize and explain鈥
Chairperson's File
Public
The recently enacted One Big Beautiful Bill Act will bring big changes to health care. AHA President and CEO Rick Pollack joined me for a Leadership Dialogue鈥
Headline
The House Ways and Means Subcommittees on Health and Oversight held a joint hearing today to discuss lessons learned, challenges and opportunities to improve鈥
Headline
The AHA today expressed support for the Medicare Mental Health Inpatient Equity Act, a bill that would eliminate the 190-day lifetime limit on inpatient鈥
Headline
The AHA July 8 wrote in opposition to the 鈥淧atient Access to Higher Quality Health Care Act鈥 (H.R. 4002), which would repeal current law banning the creation鈥
Headline
The AHA July 3 released the Health Care Plan Accountability Update for the second quarter of 2025. The update covers the latest developments in Medicare鈥